While the mechanistic link between Aβ accumulation and neuronal dysfunction in both fAD and sAD remains unclear, targeting the processing of APP and the production of Aβ within the framework of the amyloid hypothesis has remained an attractive approach for AD drug discovery in recent years. The gene discussed is APP; the disease is familial Alzheimer disease.